Paternal Antiseizure Rx Use at Conception Does Not Pose Risk to Offspring
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 23, 2024 -- Limited data indicate that paternal exposure to antiseizure medications (ASMs) at conception is unlikely to pose any major risk for adverse outcomes for offspring, according to a review published online Sept. 17 in the Journal of Neurology, Neurosurgery & Psychiatry.
Eliza Honybun, from the University of Melbourne in Australia, and colleagues conducted a systematic review to assess neurodevelopmental and anatomical outcomes in offspring born to fathers taking ASMs at the time of conception. Twenty-six studies underwent full-text review; 10 met the eligibility criteria for inclusion.
The researchers found limited evidence was available, and no clear evidence was found for an adverse impact of paternal ASM use on offspring outcomes. The few isolated adverse findings were not seen in other studies. A meta-analysis was prevented by several methodological limitations, including failure to report outcomes separately for each individual ASM, heterogeneity in measurement and outcome reporting, and small numbers of monotherapy exposures.
"While the findings summarized in our systematic review are overall reassuring for males taking ASMs, including valproate, it is clear that the potential reproductive implications of ASM exposure in males remain an underinvestigated area of research that should be prioritized over the next decade," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Preconception Hypoglycemia Linked to Adverse Pregnancy Outcomes
MONDAY, Aug. 4, 2025 -- Preconception hypoglycemia is associated with adverse pregnancy outcomes, according to a study published online July 29 in PLOS Medicine. Hanbin Wu, from...
Mental Illness Increased During, After Pregnancy for Gestational Carriers
MONDAY, Aug. 4, 2025 -- Gestational carriers seem to be more likely to be diagnosed with mental illness during and after pregnancy than those with unassisted pregnancies or...
Green Space Exposure in Pregnancy, Early Childhood May Cut Risk for Neurodevelopmental Disorders
TUESDAY, July 29, 2025 -- Living near green spaces before and during pregnancy, as well as in early childhood, may lower the risk for neurodevelopmental disorders, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.